Literature DB >> 9920958

Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?

J R O'Dell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9920958     DOI： 10.1056/NEJM199901283400411

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Evidence for ligand-independent multimerization of the IL-17 receptor.

Authors:  Jill M Kramer; Ling Yi; Fang Shen; Amarnath Maitra; Xuanmao Jiao; Tian Jin; Sarah L Gaffen
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 2.  Role of cytokines and chemokines in non-alcoholic fatty liver disease.

Authors:  Vincent Braunersreuther; Giorgio Luciano Viviani; François Mach; Fabrizio Montecucco
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

3.  Is monocyte chemotactic protein 1 elevated in aseptic loosening of TKA? A pilot study.

Authors:  Vinod Dasa; Jill M Kramer; Sarah L Gaffen; Keith L Kirkwood; William M Mihalko
Journal:  Clin Orthop Relat Res       Date:  2012-07       Impact factor: 4.176

Review 4.  Etanercept: a review of its use in rheumatoid arthritis.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

5.  Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report.

Authors:  Andrew Smyth; Diarmaid D Houlihan; Helen Tuite; Catherine Fleming; Thomas A O'Gorman
Journal:  J Med Case Rep       Date:  2010-11-17

6.  Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.

Authors:  Peter D Senter; Yousef Al-Abed; Christine N Metz; Fabio Benigni; Robert A Mitchell; J Chesney; Jianlin Han; Carlos G Gartner; Sidney D Nelson; George J Todaro; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

7.  Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis.

Authors:  R Alten; E Gromnica-Ihle; C Pohl; J Emmerich; J Steffgen; R Roscher; R Sigmund; B Schmolke; G Steinmann
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

8.  Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat.

Authors:  Bared Safieh-Garabedian; Mireille Dardenne; Jean Marie Pléau; Nayef E Saadé
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

9.  Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.

Authors:  Ryuji Ohashi; Ryuji Fukazawa; Makoto Watanabe; Hanako Tajima; Noriko Nagi-Miura; Naohito Ohno; Shinichi Tsuchiya; Yuh Fukuda; Shunichi Ogawa; Yasuhiko Itoh
Journal:  Int J Vasc Med       Date:  2013-03-31

10.  Peptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2.

Authors:  Ku-Chuan Hsiao; Renee E Brissette; Pinger Wang; Paul W Fletcher; Vanessa Rodriguez; Michael Lennick; Arthur J Blume; Neil I Goldstein
Journal:  Proteome Sci       Date:  2003-01-24       Impact factor: 2.480
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.